![logo](/logos/INSM.webp)
Insmed Incorporated
NASDAQ:INSM
71.04 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Insmed Incorporated |
Symbool | INSM |
Munteenheid | USD |
Prijs | 71.04 |
Beurswaarde | 12,208,152,960 |
Dividendpercentage | 0% |
52-weken bereik | 21.92 - 80.53 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. William H. Lewis J.D., M.B.A. |
Website | https://www.insmed.com |
An error occurred while fetching data.
Over Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)